Free Trial

Atrion (ATRI) Stock Price, News & Analysis

-1.07 (-0.23%)
(As of 05/24/2024 08:49 PM ET)
Today's Range
50-Day Range
52-Week Range
28,400 shs
Average Volume
20,696 shs
Market Capitalization
$814.76 million
P/E Ratio
Dividend Yield
Price Target

Atrion MarketRank™ Stock Analysis

Analyst Rating
Short Interest
8.86% of Float Sold Short
Dividend Strength
Based on Four Factors
News Sentiment
0.84mentions of Atrion in the last 14 days
Based on 7 Articles This Week
Insider Trading
Proj. Earnings Growth

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.42 out of 5 stars

Medical Sector

731st out of 922 stocks

Surgical & Medical Instruments Industry

84th out of 97 stocks

ATRI stock logo

About Atrion Stock (NASDAQ:ATRI)

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

ATRI Stock Price History

ATRI Stock News Headlines

Atrion (NASDAQ:ATRI) Sees Strong Trading Volume
Atrion Corporation Declares Quarterly Cash Dividend
Atrion (NASDAQ:ATRI) Downgraded to "Sell" at
Atrion: Q1 Earnings Snapshot
Atrion Reports First Quarter 2024 Results
3 Small Cap Dividend Stocks With Income And Growth
Atrion Reports Fourth Quarter And Full Year 2023 Results
Atrion Corporation Declares Quarterly Cash Dividend
Atrion Corp.
See More Headlines
Receive ATRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atrion and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/29 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 6/28 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Supplies
Current Symbol
Year Founded


Net Income
$19.41 million
Pretax Margin


Sales & Book Value

Annual Sales
$169.33 million
Cash Flow
$19.61 per share
Book Value
$137.46 per share


Free Float
Market Cap
$814.76 million
Not Optionable
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

ATRI Stock Analysis - Frequently Asked Questions

How have ATRI shares performed in 2024?

Atrion's stock was trading at $378.79 at the beginning of the year. Since then, ATRI shares have increased by 22.2% and is now trading at $462.93.
View the best growth stocks for 2024 here

When is Atrion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 13th 2024.
View our ATRI earnings forecast

How were Atrion's earnings last quarter?

Atrion Co. (NASDAQ:ATRI) announced its quarterly earnings data on Friday, May, 10th. The medical instruments supplier reported $1.59 EPS for the quarter. The medical instruments supplier had revenue of $47.33 million for the quarter. Atrion had a net margin of 10.60% and a trailing twelve-month return on equity of 7.75%.

How often does Atrion pay dividends? What is the dividend yield for Atrion?

Atrion announced a quarterly dividend on Tuesday, May 21st. Shareholders of record on Friday, June 14th will be given a dividend of $2.20 per share on Friday, June 28th. This represents a $8.80 dividend on an annualized basis and a yield of 1.90%. The ex-dividend date is Friday, June 14th.
Read our dividend analysis for ATRI

Is Atrion a good dividend stock?

Atrion (NASDAQ:ATRI) pays an annual dividend of $8.80 per share and currently has a dividend yield of 1.90%. The company has been increasing its dividend for 21 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 82.71%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for ATRI.

What ETFs hold Atrion's stock?

ETFs with the largest weight of Atrion (NASDAQ:ATRI) stock in their portfolio include ProShares Russell 2000 Dividend Growers ETF (SMDV).Invesco Nasdaq Future Gen 200 ETF (QQQS).

What is David A. Batta's approval rating as Atrion's CEO?

1 employees have rated Atrion Chief Executive Officer David A. Batta on David A. Batta has an approval rating of 100% among the company's employees. This puts David A. Batta in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 100.0% of employees surveyed would recommend working at Atrion to a friend.

What other stocks do shareholders of Atrion own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Atrion investors own include International Paper (IP), AT&T (T), WestRock (WRK), AbbVie (ABBV), Caterpillar (CAT), Eastman Chemical (EMN), Gilead Sciences (GILD), Altria Group (MO), Pfizer (PFE) and Philip Morris International (PM).

Who are Atrion's major shareholders?

Atrion's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (4.82%), ProShare Advisors LLC (1.19%), Price T Rowe Associates Inc. MD (0.43%), Public Employees Retirement System of Ohio (0.28%), Sei Investments Co. (0.10%) and California State Teachers Retirement System (0.08%). Insiders that own company stock include David A Battat, Emile A Battat, Jeffery Strickland and Preston G Athey.
View institutional ownership trends

How do I buy shares of Atrion?

Shares of ATRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ATRI) was last updated on 5/27/2024 by Staff

From Our Partners